Application 202097
- Type
- ANDA
- Sponsor
- 3M DRUG DELIVERY
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FENTANYL-12 | FENTANYL | FILM, EXTENDED RELEASE;TRANSDERMAL | 12.5MCG/HR | No | No |
| 002 | FENTANYL-25 | FENTANYL | FILM, EXTENDED RELEASE;TRANSDERMAL | 25MCG/HR | No | No |
| 003 | FENTANYL-50 | FENTANYL | FILM, EXTENDED RELEASE;TRANSDERMAL | 50MCG/HR | No | No |
| 004 | FENTANYL-75 | FENTANYL | FILM, EXTENDED RELEASE;TRANSDERMAL | 75MCG/HR | No | No |
| 005 | FENTANYL-100 | FENTANYL | FILM, EXTENDED RELEASE;TRANSDERMAL | 100MCG/HR | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A202097-001 | FENTANYL-12 | FENTANYL | 12.5MCG/HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2016-11-04 | |
| A202097-002 | FENTANYL-25 | FENTANYL | 25MCG/HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2016-11-04 | |
| A202097-003 | FENTANYL-50 | FENTANYL | 50MCG/HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2016-11-04 | |
| A202097-004 | FENTANYL-75 | FENTANYL | 75MCG/HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2016-11-04 | |
| A202097-005 | FENTANYL-100 | FENTANYL | 100MCG/HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2016-11-04 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A202097-001 | AB |
| A202097-002 | AB |
| A202097-003 | AB |
| A202097-004 | AB |
| A202097-005 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A202097-001 | FENTANYL-12 | 12.5MCG/HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2016-11-04 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A202097-002 | FENTANYL-25 | 25MCG/HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2016-11-04 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A202097-003 | FENTANYL-50 | 50MCG/HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2016-11-04 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A202097-004 | FENTANYL-75 | 75MCG/HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2016-11-04 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A202097-005 | FENTANYL-100 | 100MCG/HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2016-11-04 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A202097-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A202097-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A202097-003 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A202097-004 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A202097-005 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fentanyl system | FENTANYL | ALVOGEN | 242759ef-cb6d-4e3e-9f8d-5e31efa1f289 | 2026-03-02 | Boxed warning, Warnings, Adverse reactions | 202097 ANDA202097 47781-426 47781-428 47781-424 47781-423 47781-427 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 47781-423 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-423 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-423 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-423 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-423 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-423 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-423 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-423 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-423 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-424 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-424 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-424 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-424 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-424 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-424 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-424 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-424 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-424 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-426 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-426 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-426 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-426 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-426 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-426 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-426 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-426 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-426 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-427 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-427 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-427 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-427 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-427 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-427 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-427 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-427 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-427 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-428 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-428 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-428 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-428 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-428 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-428 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-428 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-428 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 47781-428 | Fentanyl System | Fentanyl | Alvogen | ANDA | Current |
| 55700-597 | Fentanyl System | Fentanyl | Lake Erie Medical DBA Quality Care Products LLC | ANDA | Current |
| 55700-597 | Fentanyl System | Fentanyl | Lake Erie Medical DBA Quality Care Products LLC | ANDA | Current |
| 55700-597 | Fentanyl System | Fentanyl | Lake Erie Medical DBA Quality Care Products LLC | ANDA | Current |
| 55700-972 | Fentanyl System | Fentanyl | Quality Care Products, LLC | ANDA | Current |
| 55700-973 | Fentanyl System | Fentanyl | Quality Care Products, LLC | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 76221 | ORIG | 2023-11-03 |